Ortin Global Limited (NSE:ORTINGLOBE)
16.71
-0.30 (-1.76%)
Jun 19, 2026, 3:22 PM IST
Ortin Global Market Cap
Ortin Global has a market cap or net worth of 134.25 million as of June 18, 2026. Its market cap has increased by 42.70% in one year.
Market Cap
134.25M
Enterprise Value
138.24M
Revenue
1.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.71
Market Cap Chart
Since April 12, 2007, Ortin Global's market cap has increased from 48.26M to 134.25M, an increase of 178.19%. That is a compound annual growth rate of 5.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 134.25M | 15.62% |
| Dec 31, 2025 | 116.12M | -20.22% |
| Dec 31, 2024 | 145.55M | -22.24% |
| Dec 29, 2023 | 187.18M | -2.87% |
| Dec 30, 2022 | 192.71M | -27.96% |
| Dec 31, 2021 | 267.52M | -46.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sigachi Industries | 8.38B |
| Bafna Pharmaceuticals | 3.79B |
| Valiant Laboratories | 3.73B |
| Nectar Lifesciences | 2.26B |
| Brooks Laboratories | 2.00B |
| Alpa Laboratories | 1.43B |
| Balaxi Pharmaceuticals | 1.31B |
| Par Drugs and Chemicals | 1.19B |